Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial

AIM: To evaluate the proteinuria-lowering effect of a renin inhibitor (aliskiren), compared to placebo and to an angiotensin-converting enzyme inhibitor (perindopril), in patients with non-diabetic chronic kidney disease. METHODS: A randomised, double-blind, crossover trial was performed in 14 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lizakowski, Sławomir, Tylicki, Leszek, Renke, Marcin, Rutkowski, Przemysław, Heleniak, Zbigniew, Sławińska-Morawska, Maja, Aleksandrowicz, Ewa, Łysiak-Szydłowska, Wieslawa, Rutkowski, Bolesław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Nephrology – Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510412/
https://www.ncbi.nlm.nih.gov/pubmed/23326865
http://dx.doi.org/10.1007/s11255-011-0110-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510412/
https://www.ncbi.nlm.nih.gov/pubmed/23326865
http://dx.doi.org/10.1007/s11255-011-0110-z

Ejemplares similares